Epidemiology of meningococcal disease in Switzerland, 1999-2002

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 23, Issue 7, 2004, Pages 517-522

  Ruedin, H Jaccard ^a,b   Ninet, B ^c   Pagano, E ^a   Rohner, P ^c  

^a FEDERAL OFFICE OF PUBLIC HEALTH   (Switzerland)

^b Swiss Health Observatory   (Switzerland)

^c UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLOOD GROUP TYPING; CHILD; FATALITY; HEALTH SURVEY; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; PRIORITY JOURNAL; SWITZERLAND; VACCINATION;

EID: 3242889984     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-004-1159-8     Document Type: Article

References (36)

1. Health Protection Agency (1999) Two teenagers die in an outbreak of meningococcal disease in Rotherham. Commun Dis Rep Wkly 9:9
2. Jackson LA, Schuchat A, Reeves MW, Wenger JD (1995) Serogroup C meningococcal outbreaks in the United States. An emerging threat. J Am Med Assoc 273:383-389
3. Imrey PB, Jackson LA, Ludwinski PH et al (1996) Outbreak of serogroup C meningococcal disease associated with campus bar patronage. Am J Epidemiol 143:624-630
4. Jensen ES, Schonheyder HC, Lind I, Berthelsen L, Norgard B, Sorensen HAT (2003) Neisseria meningitidis phenotypic markers and septicaemia, disease progress and case-fatality rate of meningococcal disease: a 20-year population-based historical follow-up study in a Danish county. J Med Microbiol 52:173-179
5. Shigematsu M, Davison KL, Charlett A, Crowcroft NS (2002) National enhanced surveillance of meningococcal disease in England, Wales and Northern Ireland, January 1999-June 2001. Epidemiol Infect 129:459-470
6. Erickson L, De Wals P (1998) Complications and sequelae of meningococcal disease in Quebec, Canada, 1990-1994. Clin Infect Dis 26:1159-1164
7. Baker MG, Martin DR, Kieft CE, Lennon D (2001) A 10-year serogroup B meningococcal disease epidemic in New Zealand: descriptive epidemiology, 1991-2000. J Paediatr Child Health 37:S13-S19
8. Moura AS, Pablos-Mendez A, Layton M, Weiss D (2003) Epidemiology of meningococcal disease, New York City, 1989-2000. Emerg Infect Dis 9:355-361
9. Rosenstein NE, Perkins BA, Stephens DS et al (1999) The changing epidemiology of meningococcal disease in the United States. J Infect Dis 180:1894-1901
10. Taha MK, Achtman M, Alonso JM et al (2000) Serogroup W135 meningococcal disease in Hajj pilgrims. Lancet 356:2159
11. Lingappa JR, Al Rabeah AM, Hajjeh R et al (2003) Serogroup W-135 meningococcal disease during the Hajj, 2000. Emerg Infect Dis 9:665-671
12. Taha MK, Parent DC, Schlumberger M et al (2002) Neisseria meningitidis serogroups W135 and A were equally prevalent among meningitis cases occurring at the end of the 2001 epidemics in Burkina Faso and Niger. J Clin Microbiol 40:1083-1084
13. Tribe DE, Zaia AM, Griffith JM et al (2002) Increase in meningococcal disease associated with the emergence of a novel ST-11 variant of serogroup C Neisseria meningitidis in Victoria, Australia, 1999-2000. Epidemiol Infect 128:7-14
14. Jelfs J, Munro R (2001) Epidemiology of meningococcal disease in Australia. J Paediatr Child Health 37:3-6
15. Fernandez S, Arreaza L, Santiago I et al (1999) Carriage of a new epidemic strain of Neisseria meningitidis and its relationship with the incidence of meningococcal disease in Galicia, Spain. Epidemiol Infect 123:349-357
16. Kremastinou J, Tzanakaki G, Kansouzidou A et al (1999) Recent emergence of serogroup C meningococcal disease in Greece. FEMS Immunol Med Microbiol 23:49-55
17. Davison KL, Ramsay ME, Crowcroft NS et al (1991) Estimating the burden of serogroup C meningococcal disease in England and Wales. Commun Dis Public Health 5:213-219
18. Ashton FE, Ryan JA, Borczyk A, Caugant DA, Mancino L, Huang D (1991) Emergence of a virulent clone of Neisseria meningitidis serotype 2a that is associated with meningococcal group C disease in Canada. J Clin Microbiol 29:2489-2493
19. Krizova P, Musilek-M, Kalmusova J (1997) Development of the epidemiological situation in invasive meningococcal disease in the Czech Republic caused by emerging Neisseria meningitidis clone ET-15/37. Cent Eur J Public Health 5:214-218
20. Kriz P, Musilek M, Skoczynska A, Hryniewicz W (2000) Genetic and antigenic characteristics of Neisseria meningitidis strains isolated in the Czech Republic in 1997-1998. Eur J Clin Microbiol Infect Dis 19:452-459
21. Jelfs J, Munro R, Ashto FE, Caugant DA (2000) Genetic characterization of a new variant within the ET-37 complex of Neisseria meningitidis associated with outbreaks in various parts of the world. Epidemiol Infect 125:285-298
22. Kriz P, Kriz B, Svandova E, Musilek M (1999) Antimeningococcal herd immunity in the Czech Republic - influence of an emerging clone, Neisseria meningitidis ET-15/37. Epidemiol Infect 123:193-200
23. Kriz P, Kalmusova J, Musilek M (2002) Epidemiology of invasive meningococcal disease in the Czech Republic. In: Programme and abstracts. 13th International Pathogenic Neisseria Conference, abstract no. 366
24. Tsolia MN, Theodoridou M, Tzanakaki G et al (2003) The evolving epidemiology of invasive meningococcal disease: a two-year prospective, population-based study in children in the area of Athens. FEMS Immunol Med Microbiol 36:87-94
25. Soult Rubio JA, Munoz SM, Lopez Castilla JD (2001) Meningococcal disease. New prevention strategies. An Esp Pediatr 54:65-68
26. Salisbury D (2001) Introduction of a conjugate meningococcal type C vaccine programme in the UK. J Paediatr Child Health 37:34-36
27. Salleras L, Dominguez A, Cardenosa N (2003) Impact of mass vaccination with polysaccharide conjugate vaccine against serogroup C meningococcal disease in Spain. Vaccine 21:725-728
28. Balmer P, Borrow R, Miller E (2002) Impact of meningococcal C conjugate vaccine in the UK. J Med Microbiol 51:717-722
29. Swiss Federal Office of Public Health (2002) Infections à méningocoques: Schéma de vaccination pour les personnes présentant des facteurs de risque. Bulletin OFSP no. 50:884-885. http.//www.bag.admin.ch/infekt/publ/bulletin/f/menin_impfsch_bu50.pdf
30. Frasch CE, Zollinger WD, Poolman JT (1985) Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. Rev Infect Dis 7504-7510
31. Maiden MC, Bygraves JA, Feil E et al (1998) Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci USA 95:3140-3145
32. British Society of Antimicrobial Chemotherapy (1998) BSAC standardized disc sensitivity testing method. BSAC, Birmingham
33. Statens Serum Institut (2003) Meningococcal disease 2002. Epi-News 16/17
34. Menon A, Cafferkey MT, Murphy K, Fitzgerald M, Devlin J, O'Flanagan D (2003) Impact of group C meningococcal vaccine in Ireland. In: Programme and abstracts. 21st Annual Meeting of the European Society for Paediatric Infectious Diseases, abstract no. 24
35. Mastrantonio P, Stefanelli P, Fazio C et al (2003) Serotype distribution, antibiotic susceptibility, and genetic relatedness of Neisseria meningitidis strains recently isolated in Italy. Clin Infect Dis 36:422-428
36. Scholten RJ, Bijlmer HA, Valkenburg HA, Dankert J (1994) Patient and strain characteristics in relation to the outcome of meningococcal disease: a multivariate analysis. Epidemiol Infect 112:115-124